Refine your search
-
Authors
-
Item types
-
Topics
- *Anti-Inflammatory Agents/ad [Administration & Dosage]
- *Atherosclerosis [x]
- *Atherosclerosis/dt [Drug Therapy]
- *Cardiovascular Diseases/dt [Drug Therapy]
- *Fatty Acids, Omega-3/ad [Administration & Dosage]
- *Hydroxymethylglutaryl-CoA Reductase Inhibitors
- *Hyperlipidemias
- *Risk Reduction Behavior
- *Triglycerides/ai [Antagonists & Inhibitors]
- Atherosclerosis/bl [Blood]
- Atherosclerosis/dt [Drug Therapy]
- Cardiovascular Diseases/bl [Blood]
- Cholesterol, LDL
- Dicarboxylic Acids
- Ezetimibe/tu [Therapeutic Use]
- Fatty Acids
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors/tu [Therapeutic Use]
- Hyperlipidemias/ci [Chemically Induced]
- Hyperlipidemias/dt [Drug Therapy]
- Show more
- Show less
-
Collections
-
Languages